Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives; D001665:Binding Sites; D002118:Calcium / Q000502:physiology*; D002135:Calcium-Binding Proteins / Q000037:antagonists & inhibitors*; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D002645:Chickens; D002746:Chlorpromazine / Q000378:metabolism / Q000494:pharmacology; D003864:Depression, Chemical; D003959:Diamines / Q000378:metabolism / Q000494:pharmacology; D004347:Drug Interactions; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000201:enzymology*; D009218:Myosins / Q000378:metabolism; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011299:Prenylamine / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D011494:Protein Kinases / Q000378:metabolism*; D013449:Sulfonamides / Q000378:metabolism / Q000494:pharmacology
D002135:Calcium-Binding Proteins; D002147:Calmodulin; D003959:Diamines; D013449:Sulfonamides; C017967:W 7; C024987:N(2)-dansyl-L-arginine-4-t-butylpiperidine amide; D001120:Arginine; D011494:Protein Kinases; D010727:Phosphoric Diester Hydrolases; D000251:Adenosine Triphosphatases; D009218:Myosins; D011299:Prenylamine; D002118:Calcium; D002746:Chlorpromazine